Sign Up Today and Learn More About Tempero Bio Stock
Invest in or calculate the value of your shares in Tempero Bio or other pre-IPO companies through EquityZen's platform.
Tempero Bio Stock
Tempero Bio develops treatments for Substance Use Disorders as a clinical-stage biopharmaceutical company.
About Tempero Bio Stock
Founded
2020
Headquarters
Oakland, CA, US
Industries
Software, Artificial Intelligence, Data and Analytics
Tempero Bio Press Mentions
Stay in the know about the latest news on Tempero Bio
Tempero calls time on alcohol use disorder while mulling options, according to partner
fiercebiotech • Nov 09, 2025
Alcohol Use Disorder Market Analysis and Forecasts Report 2025-2035 | Targeted Therapies, Rising Awareness, and Expanding Clinical Pipeline - ResearchAndMarkets.com
businesswire • Jul 16, 2025
Alcohol Use Disorder Market Report 2025-2035 Featuring Clearmind Medicine, Purdue Pharma, Psyence Biomedical, Eli Lilly and Co, Tempero Bio,, Nxera Pharma, Novo Nordisk, Adial, Alkermes, Lundbeck
globenewswire • Jul 09, 2025
Nxera Pharma Operational Highlights and Consolidated Results for the First Quarter 2025
globenewswire • May 04, 2025
Nxera Pharma Operational Highlights and Consolidated Results for the First Quarter 2025
biospace • May 04, 2025
Join now and verify your accreditation status to gain access to:
- Tempero Bio Current Valuation
- Tempero Bio Stock Price
- Tempero Bio Management
- Available deals in Tempero Bio and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Tempero Bio Cap Table and Funding History by Share Class and Liquidity Preferences
- Tempero Bio Revenue and Financials
- Tempero Bio Highlights
- Tempero Bio Business Model
- Tempero Bio Risk Factors
- Tempero Bio Research Report from SACRA Research
Trading Tempero Bio Stock
How to invest in Tempero Bio stock?
Accredited investors can buy pre-IPO stock in companies like Tempero Bio through EquityZen funds. These investments are made available by existing Tempero Bio shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process for buying Pre-IPO Shares.
How to sell Tempero Bio stock?
Shareholders can sell their Tempero Bio stock through EquityZen's private company marketplace. EquityZen's network includes over 430K accredited investors interested in buying private company stock. Learn more about the Shareholder liquidity process.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. See more information on Express Deals and pre-IPO exit information.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 51K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."